Treatment of acute pandysautonomia with intravenous immunoglobulin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9153616.
- Also identified by PMC identifier 486878.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Acute pandysautonomia has been suggested to be an uncommon variant of Guillain-Barre syndrome. Acute pandysautonomia does not seem to have been treated with intravenous immunoglobulin or other therapies proved efficacious in Guillain-Barre syndrome. A patient is reported with severe acute pandysautonomia who responded dramatically to intravenous immunoglobulin. The findings are consistent with a dysimmune pathogenesis for this syndrome and suggest a possible treatment for future cases.
Medical subject headings
- Autonomic Nervous System Diseases
- Immunoglobulins, Intravenous